Form 8-K - Current report:
SEC Accession No. 0001683168-24-007190
Filing Date
2024-10-17
Accepted
2024-10-17 15:13:46
Documents
13
Period of Report
2024-10-17
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cardiff_8k.htm   iXBRL 8-K 28174
  Complete submission text file 0001683168-24-007190.txt   197080

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdif-20241017.xsd EX-101.SCH 3039
3 XBRL LABEL FILE cdif-20241017_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cdif-20241017_pre.xml EX-101.PRE 24181
15 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_8k_htm.xml XML 3262
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-49709 | Film No.: 241377404
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 03 Life Sciences)